![Christoph Bausch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christoph Bausch
Operationeel Directeur bij
SAB BIOTHERAPEUTICS, INC.
Vermogen: - $ op 30-06-2026
Profiel
Christoph Bausch is the founder of Nanopore Diagnostics LLC.
Dr. Bausch is the Chief Operating Officer at SAB Biotherapeutics, Inc. since 2022.
Dr. Bausch attended the University of Nebraska for undergraduate studies, St. Louis University for an MBA, and The Ohio State University for a doctorate.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-03-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
Actieve functies van Christoph Bausch
| Bedrijven | Functie | Begin |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Operationeel Directeur | 01-05-2022 |
Eerdere bekende functies van Christoph Bausch
| Bedrijven | Functie | Einde |
|---|---|---|
Nanopore Diagnostics LLC
 Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Oprichter | - |
Opleiding van Christoph Bausch
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Nebraska
 University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanopore Diagnostics LLC
Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
